Peptide-based drugs are gaining traction due to their proven pharmacological value and favourable safety profiles. These therapeutics are effective in targeting specific disease mechanisms with minimal side effects. As a result, they are being increasingly explored in areas like oncology and metabolic disorders. Their precision and safety make them an attractive choice for pharmaceutical development.